Literature DB >> 10951448

Magnetic resonance imaging of denervated muscle: comparison to electromyography.

C M McDonald1, G T Carter, R C Fritz, M W Anderson, R T Abresch, D D Kilmer.   

Abstract

The purpose of the study is to further assess the usefulness of short TI (time to inversion) recovery (STIR) magnetic resonance imaging (MRI) in detecting denervation of skeletal muscle compared to needle electromyography (EMG). Ninety subjects with clinical evidence of peripheral nerve injury or radiculopathy underwent STIR MRI and EMG of the affected limb. In 74 (82%) of these subjects, a positive correlation was found between STIR MRI and EMG (P < 0.009). STIR MRI has a relative sensitivity of 84% and specificity of 100% for detecting denervation. A subset of 28 subjects underwent quantitative assessments of signal intensity ratio (SIR) from the STIR MRI. The rank order correlation coefficient between the SIR and abnormal spontaneous activity on EMG was 0.70 (P < 0.001). Increased signal intensity on STIR MRI corresponds closely with spontaneous activity on EMG in denervated muscle. Although less sensitive than EMG in detecting muscle denervation, STIR MRI may be a useful adjunctive diagnostic tool in this setting. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10951448     DOI: 10.1002/1097-4598(200009)23:9<1431::aid-mus16>3.0.co;2-p

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  20 in total

1.  MR imaging of the lower leg versus clinical electrophysiologic examination in the differential diagnosis of neurogenic foot drop.

Authors:  Ram Ayyar
Journal:  AJNR Am J Neuroradiol       Date:  2003-08       Impact factor: 3.825

2.  MR imaging in the differential diagnosis of neurogenic foot drop.

Authors:  Martin Bendszus; Carsten Wessig; Karlheinz Reiners; Andreas J Bartsch; Laszlo Solymosi; Martin Koltzenberg
Journal:  AJNR Am J Neuroradiol       Date:  2003-08       Impact factor: 3.825

3.  Long-term reproducibility of phantom signal intensities in nonuniformity corrected STIR-MRI examinations of skeletal muscle.

Authors:  Alain R Viddeleer; Paul E Sijens; Peter M A van Ooijen; Paul D L Kuypers; Steven E R Hovius; Matthijs Oudkerk
Journal:  MAGMA       Date:  2009-02-24       Impact factor: 2.310

4.  The clinical presentation of chronic whiplash and the relationship to findings of MRI fatty infiltrates in the cervical extensor musculature: a preliminary investigation.

Authors:  James Elliott; Michele Sterling; Jon Timothy Noteboom; Julia Treleaven; Graham Galloway; Gwendolen Jull
Journal:  Eur Spine J       Date:  2009-08-12       Impact factor: 3.134

5.  Muscle MRI STIR signal intensity and atrophy are correlated to focal lower limb neuropathy severity.

Authors:  N Deroide; V Bousson; L Mambre; E Vicaut; J D Laredo; Nathalie Kubis
Journal:  Eur Radiol       Date:  2014-09-26       Impact factor: 5.315

Review 6.  The clinical laboratory evaluation of the patient with noninflammatory myopathy.

Authors:  R L Wortmann; G D Vladutiu
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.592

7.  Changes in muscle T2 relaxation properties following spinal cord injury and locomotor training.

Authors:  Min Liu; Prodip Bose; Glenn A Walter; Douglas K Anderson; Floyd J Thompson; Krista Vandenborne
Journal:  Eur J Appl Physiol       Date:  2006-04-25       Impact factor: 3.078

8.  MRI of lumbar trunk muscles in patients with Parkinson's disease and camptocormia.

Authors:  N G Margraf; A Rohr; O Granert; J Hampel; A Drews; G Deuschl
Journal:  J Neurol       Date:  2015-05-01       Impact factor: 4.849

9.  Sequential MR imaging of denervated muscle: experimental study.

Authors:  Martin Bendszus; Martin Koltzenburg; Carsten Wessig; Laszlo Solymosi
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

10.  Muscle MRI in severe Guillain-Barré syndrome with motor nerve inexcitability.

Authors:  María J Sedano; Ana Canga; Carmen de Pablos; José M Polo; José Berciano
Journal:  J Neurol       Date:  2013-01-31       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.